Translational Research Institute for Metabolism and Diabetes, Florida   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Orlando FL United States (2009)

Organization Overview

First Clinical Trial
2011
NCT01616082
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Study Principal Investigator | Translational Reseach institute for Metabolism and Diabetes | Translational Research Institute for Metabolism and Diabetes | Translational Research Institute for Metabolism and Diabetes, Florida